Fatal reactivation of occult hepatitis B virus infection after rituximab and chemotherapy in lymphoma: Necessity of antiviral prophylaxis

Onkologie

Volumn 33, Issue 10, 2010, Pages 537-539

  Zhang, Beibei ^a   Wang, Junxue ^a   Xu, Wensheng ^a   Wang, Lei ^a   Ni, Wu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Hepatitis B Virus; Lymphoma; Reactivation; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ENTECAVIR; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADRENAL BIOPSY; ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; HEPATITIS B; HUMAN; LIVER FUNCTION; MALE; MULTIPLE CYCLE TREATMENT; PROPHYLAXIS; VIRUS REACTIVATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; HEPATITIS B; HUMANS; LYMPHOMA; MALE; MIDDLE AGED;

EID: 77957838618     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319696     Document Type: Article

References (9)

1. Wang F, Xu RH, Luo HY, Zhang DS, Jiang WQ, Huang HQ, Sun XF, Xia ZJ, Guan ZZ: Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma. BMC Cancer 2008;8:115.
2. Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK: Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009;27:605-611.
3. Van der Kolk LE, Baars JW, Prins MH, van Oers MH: Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 2002;100:2257-2259.
4. European Association for The Study of The Liver: EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227-242.
5. Raimondo G, Pollicino T, Cacciola I, Squadrito G: Occult hepatitis B virus infection. J Hepatol 2007;46:160-170.
6. Liang R: How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood 2009;113:3147-3153.
7. Van der Hilst CS, Ijtsma AJ, Slooff MJ, Tenvergert EM: Cost of liver transplantation. A systematic review and meta-analysis comparing the United States with other OECD countries. Med Care Res Rev 2009;66:3-22.
8. Dervite I, Hober D, Morel P: Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med 2001;344:68-69.
9. Garcia-Rodriguez MJ, Canales MA, Hernandez-Maraver D, Hernandez-Navarro F: Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment? Am J Hematol 2008;83:673-675.